Long-term advanced therapy with bosentan improves symptoms and the time to clinical worsening in the Japanese patients with inoperable chronic thromboembolic pulmonary hypertension

DOI Open Access

Search this article

Journal

Details 詳細情報について

Report a problem

Back to top